|
1
|
Al-Muhtaseb S: Serum and saliva protein
levels in females with breast cancer. Oncol Lett. 8:2752–2756.
2014.PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H
and Zou X: Report of cancer incidence and mortality in China, 2010.
Ann Transl Med. 2:612014.PubMed/NCBI
|
|
4
|
O'Bryan JP, Frye RA, Cogswell PC, Neubauer
AA, Kitch B, Prokop C, Espinosa R III, Le Beau M, Earp HT and Liu
ET: axl, a transforming gene isolated from primary human myeloid
leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell
Biol. 11:5016–5031. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Korshunov V: Axl-dependent signalling: A
clinical update. Clin Sci (Lond). 122:361–368. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Jia L, Ren D, Liu C, Gong Y, Wang N,
Zhang X and Zhao Y: Axl mediates tumor invasion and
chemosensitivity through PI3K/Akt signaling pathway and is
transcriptionally regulated by slug in breast carcinoma. IUBMB
Life. 66:507–518. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yanagita M, Arai H, Nakano T, Ohashi K,
Mizuno K, Fukatsu A, Doi T and Kita T: Gas6 induces mesangial cell
proliferation via latent transcription factor STAT3. J Biol Chem.
276:42364–42369. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tai K, Shieh Y, Lee C, Shiah S and Wu C:
Axl promotes cell invasion by inducing MMP-9 activity through
activation of NF-kappaB and Brg-1. Oncogene. 27:4044–4055. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim J and Thiery J: Epithelial-mesenchymal
transitions: Insights from development. Development. 139:3471–3486.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu CW, Li AF, Chi CW, Lai CH, Huang CL, Lo
SS, Lui WY and Lin WC: Clinical significance of AXL kinase family
in gastric cancer. Anticancer Res. 22:1071–1078. 2002.PubMed/NCBI
|
|
11
|
Ishikawa M, Sonobe M, Nakayama E,
Kobayashi M, Kikuchi R, Kitamura J, Imamura N and Date H: Higher
expression of receptor tyrosine kinase Axl, and differential
expression of its ligand, Gas6, predict poor survival in lung
adenocarcinoma patients. Ann Surg Oncol. 20:(Suppl 3). S467–S476.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sayan A, Stanford R, Vickery R, Grigorenko
E, Diesch J, Kulbicki K, Edwards R, Pal R, Greaves P,
JarielEncontre I, et al: Fra-1 controls motility of bladder cancer
cells via transcriptional upregulation of the receptor tyrosine
kinase AXL. Oncogene. 31:1493–1503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Avilla E, Guarino V, Visciano C, Liotti F,
Svelto M, Krishnamoorthy G, Franco R and Melillo R: Activation of
TYRO3/AXL tyrosine kinase receptors in thyroid cancer. Cancer Res.
71:1792–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koorstra JB, Karikari CA, Feldmann G,
Bisht S, Rojas PL, Offerhaus GJ, Alvarez H and Maitra A: The Axl
receptor tyrosine kinase confers an adverse prognostic influence in
pancreatic cancer and represents a new therapeutic target. Cancer
Biol Ther. 8:618–626. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Craven RJ, Xu LH, Weiner TM, Fridell YW,
Dent GA, Srivastava S, Varnum B, Liu ET and Cance WG: Receptor
tyrosine kinases expressed in metastatic colon cancer. Int J
Cancer. 60:791–797. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu W, Bi C, Credille KM, Manro JR, Peek
VL, Donoho GP, Yan L, Wijsman JA, Yan SB and Walgren RA: Inhibition
of tumor growth and metastasis in non-small cell lung cancer by
LY2801653, an inhibitor of several oncokinases, including MET. Clin
Cancer Res. 19:5699–5710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mahadevan D, Cooke L, Riley C, Swart R,
Simons B, Croce K Della, Wisner L, Iorio M, Shakalya K, Garewal H,
et al: A novel tyrosine kinase switch is a mechanism of imatinib
resistance in gastrointestinal stromal tumors. Oncogene.
26:3909–3919. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martinelli E, Martini G, Cardone C,
Troiani T, Liguori G, Vitagliano D, Napolitano S, Morgillo F,
Rinaldi B, Melillo R, et al: AXL is an oncotarget in human
colorectal cancer. Oncotarget. 6:23281–23296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 649. Springer;
New York: 2010
|
|
20
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, PiccartGebhart M, Thurlimann B and Senn HJ: Panel members:
Personalizing the treatment of women with early breast cancer:
Highlights of the St Gallen International Expert Consensus on the
Primary Therapy of Early Breast Cancer 2013. Ann Oncol.
24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carlson RW, Moench SJ, Hammond ME, Perez
EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G,
Gradishar WJ, et al: HER2 testing in breast cancer: NCCN Task Force
report and recommendations. J Natl Compr Canc Netw. 4:(Suppl 3).
S1–S22; quiz S23-S24. 2006.
|
|
22
|
Shiozawa Y, Pedersen EA, Patel LR, Ziegler
AM, Havens AM, Jung Y, Wang J, Zalucha S, Loberg RD, Pienta KJ and
Taichman RS: GAS6/AXL axis regulates prostate cancer invasion,
proliferation and survival in the bone marrow niche. Neoplasia.
12:116–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song X and Wang H, Logsdon CD, Rashid A,
Fleming JB, Abbruzzese JL, Gomez HF, Evans DB and Wang H:
Overexpression of receptor tyrosine kinase Axl promotes tumor cell
invasion and survival in pancreatic ductal adenocarcinoma. Cancer.
117:734–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bellosta P, Zhang Q, Goff S and Basilico
C: Signaling through the ARK tyrosine kinase receptor protects from
apoptosis in the absence of growth stimulation. Oncogene.
15:2387–2397. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Holland SJ, Powell MJ, Franci C, Chan EW,
Friera AM, Atchison RE, McLaughlin J, Swift SE, Pali ES, Yam G, et
al: Multiple roles for the receptor tyrosine kinase axl in tumor
formation. Cancer Res. 65:9294–9303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berclaz G, Altermatt HJ, Rohrbach V,
Kieffer I, Dreher E and Andres AC: Estrogen dependent expression of
the receptor tyrosine kinase axl in normal and malignant human
breast. Ann Oncol. 12:819–824. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ahmed L, Nalwoga H, Arnes J, Wabinga H,
Micklem D and Akslen L: Increased tumor cell expression of Axl is a
marker of aggressive features in breast cancer among African women.
APMIS. 123:688–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
D'Alfonso TM, Hannah J, Chen Z, Liu Y,
Zhou P and Shin SJ: Axl receptor tyrosine kinase expression in
breast cancer. J Clin Pathol. 67:690–696. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Neve R, Chin K, Fridlyand J, Yeh J,
Baehner F, Fevr T, Clark L, Bayani N, Coppe J, Tong F, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Linden H, Anderson B and Li C:
Trends in 5-year survival rates among breast cancer patients by
hormone receptor status and stage. Breast Cancer Res Treat.
147:609–616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haffty B, Yang Q, Reiss M, Kearney T,
Higgins S, Weidhaas J, Harris L, Hait W and Toppmeyer D:
Locoregional relapse and distant metastasis in conservatively
managed triple negative early-stage breast cancer. J Clin Oncol.
24:5652–5657. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dent R, Trudeau M, Pritchard KL, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rakha E, ElSayed M, Green A, Lee A,
Robertson J and Ellis I: Prognostic markers in triple-negative
breast cancer. Cancer. 109:25–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
